Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

A child's chronic use of Senna caused liver damage and a severe decrease in blood cells, but improved after stopping Senna and getting treatment.

Certain skin proteins can form anchoring structures without the protein AMACO.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Host cells are crucial for the maturation of reconstructed hair follicles.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Sertraline, an antidepressant, may rarely cause hair loss.

Hair loss in a child was an early sign of Crohn's disease.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Th22 cells are essential for Tβ15-induced hair growth in mice.

PRP therapy with specific growth factors improves hair density and thickness in androgenic alopecia.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Sodium valproate caused vomiting in 20% of children under 2 years old, with other side effects like hair loss and loss of appetite also noted.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.